Fresenius Kabi USA, LLC: Device Recall

Recall #Z-2721-2024 · 08/01/2024

Class I: Dangerous

Recall Details

Recall Number: Z-2721-2024
Classification: Class I
Product Type: Device
Recalling Firm: Fresenius Kabi USA, LLC
Status: Ongoing
Date Initiated: 08/01/2024
Location: North Andover, MA, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 180 cases/4,500 pieces

Reason for Recall

A defect may cause an uncontrolled medication flow condition which may result in a dose greater than prescribed for the patient (i.e., medication overdose).

Product Description

LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty 25), Product Code: SET-0013-25. for intravenous infusion.

Distribution Pattern

US Distribution to states of: CO, ID, NJ, UT.

Other Recalls by Fresenius Kabi USA, LLC

Class II: Risk 11/21/2025

Emphasizing instructions for LVP duration programming located in the IFU.
Class I: Dangerous 11/14/2025

Software version 5.10.1 and earlier contain anomalies that have the potential to cause serious patient harm or death.
Class I: Dangerous 11/06/2025

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Class II: Risk 11/03/2025

Downstream Occlusion alarms may occur during procedures using low flow infusion rates when a check valve* is added to the Ivenix Administration Set.
Class I: Dangerous 11/03/2025

Incorrect assembly of specific lot of LVP Primary Administration Set that could result in serious patient injury.

View all recalls by Fresenius Kabi USA, LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.